alpha,beta-methyleneadenosine 5'-triphosphate has been researched along with 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Starke, K; Stoffel, D; von Kügelgen, I | 1 |
| Barraco, RA; Ergene, E; O'Leary, DS; Scislo, TJ | 1 |
| O'Leary, DS; Scislo, TJ | 2 |
| Kimura, J; Matsuoka, I; Nakanishi, H; Ohkubo, S | 1 |
| Diniz, C; Gonçalves, J; Leal, S | 1 |
| Capasso, A; Gallo, C | 1 |
7 other study(ies) available for alpha,beta-methyleneadenosine 5'-triphosphate and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine
| Article | Year |
|---|---|
P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Antihypertensive Agents; Atropine; Desipramine; Dose-Response Relationship, Drug; Electric Stimulation; Heart Atria; Indomethacin; Male; Norepinephrine; Phenethylamines; Protein Synthesis Inhibitors; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Receptors, Purinergic P2; Suramin; Triazines; Xanthines; Yohimbine | 1995 |
Activation of purinergic receptor subtypes in the nucleus tractus solitarius elicits specific regional vascular response patterns.
Topics: Adenosine; Adenosine Triphosphate; Anesthesia; Animals; Antihypertensive Agents; Baroreflex; Brain Chemistry; Cardiovascular Physiological Phenomena; Cardiovascular System; Male; Microinjections; Phenethylamines; Purinergic Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Regional Blood Flow; Solitary Nucleus | 1996 |
Differential control of renal vs. adrenal sympathetic nerve activity by NTS A2a and P2x purinoceptors.
Topics: Adenosine; Adenosine Triphosphate; Adrenal Glands; Animals; Blood Pressure; Denervation; Glutamic Acid; Heart Rate; Kidney; Male; Microinjections; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Receptors, Purinergic P2; Sinus of Valsalva; Solitary Nucleus; Sympathetic Nervous System; Vagotomy | 1998 |
Effects of P(1) and P2 receptor antagonists on beta, gamma-methyleneATP- and CGS21680-induced cyclic AMP formation in NG108-15 cells.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Cyclic AMP; Enzyme Inhibitors; Kinetics; Phenethylamines; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Rats; Tumor Cells, Cultured | 2000 |
Differential role of ionotropic glutamatergic mechanisms in responses to NTS P(2x) and A(2a) receptor stimulation.
Topics: Adenosine; Adenosine Triphosphate; Adrenal Glands; Animals; Excitatory Amino Acid Antagonists; Hemodynamics; Kidney; Kynurenic Acid; Male; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Glutamate; Receptors, Purinergic P1; Receptors, Purinergic P2; Solitary Nucleus; Sympathetic Nervous System | 2000 |
Regional differences in the adenosine A(2) receptor-mediated modulation of contractions in rat vas deferens.
Topics: Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Epididymis; Immunohistochemistry; In Vitro Techniques; Male; Muscle Contraction; Norepinephrine; Phenethylamines; Prostate; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Theobromine; Triazines; Triazoles; Vas Deferens; Xanthines | 2003 |
Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Triphosphate; Analgesics, Opioid; Animals; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine; Morphine Dependence; Muscle, Smooth; Naloxone; Narcotic Antagonists; Narcotics; Phenethylamines; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinidine; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Purinergic P2; Substance Withdrawal Syndrome; Theobromine; Theophylline | 2009 |